Cargando…
Clinical and Molecular Characterization of PMP22 point mutations in Taiwanese patients with Inherited Neuropathy
Point mutations in the peripheral myelin protein 22 (PMP22) gene have been identified to cause demyelinating Charcot-Marie-Tooth disease (CMT) and hereditary neuropathy with liability to pressure palsy (HNPP). To investigate the mutation spectrum of PMP22 in Han-Chinese population residing in Taiwan...
Autores principales: | Liao, Yi-Chu, Tsai, Pei-Chien, Lin, Thy-Sheng, Hsiao, Cheng-Tsung, Chao, Nai-Chen, Lin, Kon-Ping, Lee, Yi-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681590/ https://www.ncbi.nlm.nih.gov/pubmed/29127354 http://dx.doi.org/10.1038/s41598-017-14771-5 |
Ejemplares similares
-
Candidate imaging biomarkers for
PMP22
‐related inherited neuropathies
por: Roth, Alison R., et al.
Publicado: (2022) -
Clinical and Molecular Characterization of BSCL2 Mutations in a Taiwanese Cohort with Hereditary Neuropathy
por: Hsiao, Cheng-Tsung, et al.
Publicado: (2016) -
A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice
por: Stavrou, Marina, et al.
Publicado: (2022) -
RUNX represses Pmp22 to drive neurofibromagenesis
por: Hall, Ashley, et al.
Publicado: (2019) -
Partial Gene Deletions of PMP22 Causing Hereditary Neuropathy with Liability to Pressure Palsies
por: Cho, Sun-Mi, et al.
Publicado: (2014)